drugset / Trial / NCT03581409

Comparison of Two Different Antiplatelet Preparations for an Unruptured Intracranial Aneurysm

NCT03581409 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

Perform a randomized comparison study of dual-antiplatelet (aspirin, prasugrel) and triple-antiplatelet (aspirin, clopidogrel, and cilostazol) preparation using P2Y12 assay in patients with high on-treatment platelet reactivity undergoing stent-assisted coil embolization for an unruptured intracranial aneurysm

Timeline

Start
2018-10-24
Primary completion
2021-01-22
Completion
2021-01-22

Outcome

Met primary endpoint

paper The thromboembolic event rate was low in the modified preparation group (1 of 63 [1.6%]) compared with the standard preparation group (7 of 63 [11.1%] PMID 26010803 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cilostazol Small molecule 200 mg —
Subject Clopidogrel Small molecule 75 mg —
Subject Prasugrel Small molecule 5 mg —
Background Aspirin Small molecule 100 mg —

Indications